Biovision Biomedical Technology

Shanghai, China · Founded 2021 · Privately Held (backing)

Operator of a clinical-stage biopharmaceutical company intended to focus on the discovery, development, and commercialization of novel targeted radiopharmaceuticals to address significant unmet… Biovision Biomedical Technology is based in Shanghai, China and was founded in 2021. It has raised $42.3 million.

Last price · $/share
—
Implied valuation
—
Total raised
$42.3M
Last round
—

Who backs Biovision Biomedical Technology?

10 investors
InvestorType
CICC CapitalPE / buyout
Yijing CapitalVenture capital
VI VenturesVenture capital
Elikon Venture—
Gaorong Ventures—
Hangzhou Tigermed Consulting Company—
Huajin Securities Investment—
Kaitai Capital—
Trinity Innovation Fund—
Zhuhai Huajin Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Biovision Biomedical Technology investors

10 investors are on record for Biovision Biomedical Technology, including CICC Capital, Yijing Capital, VI Ventures and Elikon Venture.

Free account
More of Biovision Biomedical Technology with a free account
  • ·Watch Biovision Biomedical Technology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Biovision Biomedical Technology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View